
Medi Assist (MEDIASSIST) | Stock Overview & Key Data
Medi Assist Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹716.15 on September 16, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Medi Assist MEDIASSIST | 38.56B Small-cap | -0.07% | 1.18% | 0.87% | 9.44% | -13.60% | -17.24% | 13.65% | 13.65% |
Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 2.80% | 3.33% | -2.89% | -7.84% | -13.69% | -14.60% | 70.78% | 218.03% |
Divi's Laboratories DIVISLAB | 1.61T Large-cap | 3.10% | -4.83% | -14.69% | 1.79% | -3.41% | 8.12% | 57.02% | 83.89% |
Torrent TORNTPHARM | 1.24T Large-cap | -1.30% | -2.55% | 5.42% | 8.22% | 2.81% | 1.18% | 123.52% | 25.54% |
Cipla CIPLA | 1.22T Large-cap | 1.22% | -3.85% | 0.60% | 1.47% | 2.59% | 5.43% | 34.25% | 88.97% |
Max Healthcare MAXHEALTH | 1.05T Large-cap | -4.82% | -7.99% | -17.84% | -4.65% | -6.18% | 15.42% | 157.02% | 865.85% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MEDIASSIST's 52-week high and low?
- In the last 52 weeks, Medi Assist reached a high of ₹689.25 (on October 14, 2024) and a low of ₹415.25 (on April 7, 2025).
- What is the market cap and P/E ratio for MEDIASSIST?
- Curious about Medi Assist's size and valuation? Its market capitalization stands at 38.56B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.28, and the forward P/E (looking ahead) is 26.83.
- Does MEDIASSIST pay dividends? If so, what's the yield?
- Yes, Medi Assist is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.82%, and the company has paid an average of ₹1.33 per share annually over the past 3 years.
- Who are Medi Assist's main competitors or similar companies to consider before investing?
When looking at Medi Assist, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -14.60% 70.78% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 8.12% 57.02% Torrent
TORNTPHARM1.24T Healthcare Drug Manufacturers - Specialty & Generic 1.18% 123.52% Cipla
CIPLA1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.43% 34.25% Max Healthcare
MAXHEALTH1.05T Healthcare Medical Care Facilities 15.42% 157.02% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medi Assist Healthcare Services Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medi Assist's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.46%, the Debt to Equity ratio from the most recent quarter is 36.89, and its Gross Profit Margin stands at 58.09%.
- What is the recent revenue and earnings growth for MEDIASSIST?
- Looking at Medi Assist's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.60%, and quarterly earnings saw a YoY growth of 19.00%.
- How much of MEDIASSIST stock is held by insiders and institutions?
- Wondering who owns Medi Assist stock? Company insiders (like executives and directors) hold about 8.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 76.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.